Valley National Advisers’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35
Closed -$5K 744
2024
Q2
$5K Buy
35
+24
+218% +$3.42K ﹤0.01% 738
2024
Q1
$1K Buy
11
+7
+175% +$1.17K ﹤0.01% 1014
2023
Q4
$1K Buy
4
+1
+33% +$362 ﹤0.01% 1013
2023
Q3
$2K Buy
+3
New +$1.35K ﹤0.01% 797

Other funds holding AGL

Valley National Advisers's AGL Position: Q3 2024 in Review

Valley National Advisers sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 35 shares — an estimated $5K sold.

Valley National Advisers first reported a position in AGL in Q3 2023 and held it in 4 quarters. The position peaked at $5K in Q2 2024. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Valley National Advisers reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Valley National Advisers sold 35 Agilon Health shares in Q3 2024, an estimated $5K.
  • Valley National Advisers first reported a position in Agilon Health in Q3 2023 and held it in 4 quarters.
  • Valley National Advisers's Agilon Health position peaked at $5K in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Valley National Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.